Wilfried Wehner

Title: Wilfried Wehner: Innovator in Biocompatible Hip-Joint Technology

Introduction

Wilfried Wehner is a notable inventor based in Karl-Marx-Stadt, Germany. He has made significant contributions to the field of medical technology, particularly in the development of biocompatible hip-joint sockets. His innovative approach has the potential to improve patient outcomes in hip replacement surgeries.

Latest Patents

Wehner holds a patent for a "Single part biocompatible hip-joint socket moorable without cement." This invention relates to a single-part, biocompatible hip-joint socket that can be used universally in combination with hip-joint endoprostheses. It is especially suitable for the treatment of dysplastic hips. The joint socket is constructed from titanium or tantalum metals, forming a barrier layer, or from alloys thereof. It features a perforated flange ring for secure attachment to the pelvic bone and is coated with specific function characteristic oxide layers containing bioactivators. Notably, the implantation of this hip-joint socket does not require any special operating instructions, thereby minimizing the need for additional surgical procedures.

Career Highlights

Wehner's career is marked by his dedication to advancing medical technology. His work at Technische Universität Karl-Marx-Stadt has positioned him as a key figure in the field of orthopedic innovations. His patent reflects his commitment to improving surgical techniques and patient care.

Collaborations

Throughout his career, Wehner has collaborated with esteemed colleagues such as Peter Kurze and Klaus Rabending. These partnerships have fostered an environment of innovation and have contributed to the development of groundbreaking medical solutions.

Conclusion

Wilfried Wehner's contributions to the field of biocompatible hip-joint technology exemplify the impact of innovative thinking in medicine. His patented invention has the potential to transform hip replacement procedures, enhancing the quality of life for many patients.